The Process and Outcomes of Treatment Decision-Making Communication Between Oncologists and Newly Diagnosed Female Breast-Cancer Patients
- To determine the association between women's and physicians' participatory
communication behaviors (e.g., patients asking questions, physicians soliciting
questions) on treatment decision-making process and health outcomes.
- To capture the language used in the treatment-decision interactions.
- To assess the degree of variation in the language used among physicians and patients
who are active participants and those who are less inclined to participate in the
treatment decision-making interaction.
OUTLINE: Patients and their companions undergo consultation with the physician for treatment
decision making. The treatment discussion is audio/videotaped for approximately 45 minutes.
Patients complete one short survey prior to physician consultation. After the treatment
discussion, patients complete two short surveys, one immediately after the visit in the
waiting room before leaving for the day, and the second one a week after the visit by a
web-based survey or by mail.
PROJECTED ACCRUAL: A total of 300 women with breast cancer and 600 companions of these women
will be accrued for this study.
Observational Model: Cohort, Time Perspective: Prospective
The association between patients' and physicians' participatory communication and psychosocial outcomes.
Pre- and post-Initial treatment decision making visit
Thomas J. Kearney, MD
Cancer Institute of New Jersey
United States: Food and Drug Administration
|Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School||New Brunswick, New Jersey 08903|